Coty Faces Lawsuit, Fragrance Business Hit Hard
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 01 2026
0mins
Should l Buy COTY?
Source: Newsfilter
- Legal Challenges: Coty is facing a lawsuit from DB Ventures for severe breaches of the licensing agreement, with allegations of mismanagement leading to David Beckham fragrances being sold at gas stations, which damages brand reputation and exacerbates challenges in Coty's fragrance business.
- Revenue Decline Risks: While Coty's fragrance segment is its primary revenue driver, it is shrinking due to the impending loss of Gucci's license and intensified competition, with third-quarter adjusted EBITDA expected to fall to $100-$110 million, significantly below analysts' average forecast of $201.6 million.
- Stock Price Plunge: Coty's shares have plummeted 78% over the past year, hitting a record low in early April, placing interim CEO Markus Strobel under pressure to revitalize the company, especially with the anticipated loss of the lucrative Gucci brand.
- Strategic Review Initiatives: Coty has launched a strategic review of its consumer cosmetics business, assessing options such as partnerships, divestitures, and spin-offs for brands like Rimmel and Max Factor, aiming to restore sales growth by focusing on core brands.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COTY?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COTY
Wall Street analysts forecast COTY stock price to rise
12 Analyst Rating
1 Buy
9 Hold
2 Sell
Hold
Current: 2.500
Low
2.50
Averages
4.30
High
10.00
Current: 2.500
Low
2.50
Averages
4.30
High
10.00
About COTY
Coty Inc. is a beauty company with a portfolio of brands across fragrance, color cosmetics, and skin and body care. The Company has a diverse portfolio of brands, which includes both owned and licensed. Its brand portfolio is classified into two segments: Consumer beauty and Prestige. The consumer beauty brands include Adidas, Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, Mexx, LeGer by Lena Gercke, Monange, Nautica, Paixao, Rimmel, Risque, Sally Hansen, and Vera Wang. Its prestige brands include Burberry, Calvin Klein, Chloe, Davidoff, Escada, Gucci, Hugo Boss, Jil Sander, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Miu Miu, Orveda, and Tiffany & Co. Its mass beauty brands are primarily sold through hypermarkets, supermarkets, drug stores and pharmacies, mid-tier department stores, traditional food and drug retailers, and dedicated e-commerce retailers. It markets, sells and distributes its products in over 120 countries and territories.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Coty Inc. Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Coty Inc. to recover damages for investors who purchased Coty securities between November 5, 2025, and February 4, 2026, reflecting investor disappointment in the company's future prospects.
- False Statements Allegations: The complaint alleges that Coty executives made materially false and misleading statements regarding the company's growth and profitability, failing to disclose the underperformance in its Consumer Beauty segment and the slowing growth in the beauty market.
- Profit Pressure Evident: The lawsuit highlights that Coty's margins were pressured by increased marketing expenditures, which negatively impacted overall profitability and heightened investor concerns about the company's financial health.
- No Cost to Investors: Bronstein, Gewirtz & Grossman, LLC emphasizes that they operate on a contingency fee basis, meaning investors incur no costs unless the lawsuit is successful, thereby lowering the barrier for investor participation in the class action.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased its stock between November 5, 2025, and February 4, 2026, following a Q2 2026 earnings report that revealed serious operational issues, causing the stock price to drop over 8% on the announcement day.
- Executive Departure: The abrupt departure of CEO Sue Y. Nabi on December 12, 2025, without explanation, has raised significant concerns regarding corporate governance and transparency, exacerbating investor anxiety about the company's future.
- Deteriorating Financial Performance: The Q2 2026 earnings report revealed that Coty's Consumer Beauty segment operating income plummeted over 70% year-over-year, while Prestige fragrance income fell over 18%, indicating severe challenges in market competitiveness and operational efficiency.
- Investor Confidence Eroded: Coty withdrew its FY 2026 EBITDA and free cash flow guidance, with management projecting mid-single-digit revenue declines for Q3, highlighting significant uncertainties regarding the company's profitability and market share moving forward.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit following its Q2 2026 earnings report, which revealed serious operational issues, representing investors who purchased shares between November 5, 2025, and February 4, 2026, indicating strong investor dissatisfaction with the company's transparency.
- Stock Price Impact: Following the abrupt departure of CEO Nabi, Coty's stock price fell over 8% on February 5, 2026, reflecting market pessimism regarding the company's future prospects, particularly after its performance failed to meet expectations.
- Financial Performance: The Q2 2026 report revealed that Consumer Beauty's operating income plummeted over 70% year-over-year, while Prestige fragrance operating income also fell over 18%, highlighting significant challenges the company faces in a competitive market.
- Investigation Progress: Hagens Berman is investigating whether Coty intentionally misled investors regarding its business trends, and if proven, this could have substantial implications for the company's reputation and future financing capabilities.
See More
Coty Inc. Faces Class Action Lawsuit for Misleading Statements
- Lawsuit Reminder: The Schall Law Firm is reminding investors of a class action lawsuit against Coty Inc. for violations of securities laws, concerning securities transactions from November 5, 2025, to February 4, 2026, with a deadline to contact the firm by May 22, 2026, to participate.
- False Statements: The complaint alleges that Coty made false and misleading statements regarding its growth prospects for fiscal year 2026, as the company’s Consumer Beauty segment was underperforming, leading to significant investor losses.
- Market Reaction: As the market became aware of Coty's true performance, investor losses intensified, indicating a significant discrepancy between the company's growth promises and actual market performance, which negatively impacted its stock price and investor confidence.
- Legal Consequences: The case has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act may become absent class members, potentially forfeiting their claims.
See More
Coty Class Action Lawsuit Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action, as those who do not will not be represented by counsel.
- Fee Arrangement: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, allowing investors to seek compensation without financial burden.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth emerged, highlighting underperformance in the consumer beauty sector.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, demonstrating its extensive experience and success in handling such cases.
See More
Multiple Companies Face Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics faces a class action lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, potentially leading to significant negative impacts on the company's financial condition.
- Coty Performance Decline: Coty Inc. is under scrutiny in a class action lawsuit covering November 5, 2025, to February 4, 2026, with claims that its Consumer Beauty segment underperformed, increased marketing investments compressed margins, and slowing growth in the Prestige fragrance market rendered the company's positive statements misleading.
- Super Micro Sales Violations: Super Micro Computer is implicated in a class action lawsuit for the period from February 2, 2024, to March 19, 2026, alleging that a significant portion of its server sales to Chinese companies violated U.S. export control laws, with material weaknesses in compliance controls leading to misleading positive statements about the company's operations.
- ImmunityBio Capability Overstatement: ImmunityBio faces a class action lawsuit for the period from January 19, 2026, to March 24, 2026, alleging that executive Soon-Shiong materially overstated Anktiva's capabilities, resulting in misleading positive statements about the company's business and operations, which could undermine investor confidence.
See More
Coty Inc. Faces Class Action Lawsuit Over Securities Violations
- Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Coty Inc. to recover damages for investors who purchased Coty securities between November 5, 2025, and February 4, 2026, reflecting investor disappointment in the company's future prospects.
- False Statements Allegations: The complaint alleges that Coty executives made materially false and misleading statements regarding the company's growth and profitability, failing to disclose the underperformance in its Consumer Beauty segment and the slowing growth in the beauty market.
- Profit Pressure Evident: The lawsuit highlights that Coty's margins were pressured by increased marketing expenditures, which negatively impacted overall profitability and heightened investor concerns about the company's financial health.
- No Cost to Investors: Bronstein, Gewirtz & Grossman, LLC emphasizes that they operate on a contingency fee basis, meaning investors incur no costs unless the lawsuit is successful, thereby lowering the barrier for investor participation in the class action.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit representing investors who purchased its stock between November 5, 2025, and February 4, 2026, following a Q2 2026 earnings report that revealed serious operational issues, causing the stock price to drop over 8% on the announcement day.
- Executive Departure: The abrupt departure of CEO Sue Y. Nabi on December 12, 2025, without explanation, has raised significant concerns regarding corporate governance and transparency, exacerbating investor anxiety about the company's future.
- Deteriorating Financial Performance: The Q2 2026 earnings report revealed that Coty's Consumer Beauty segment operating income plummeted over 70% year-over-year, while Prestige fragrance income fell over 18%, indicating severe challenges in market competitiveness and operational efficiency.
- Investor Confidence Eroded: Coty withdrew its FY 2026 EBITDA and free cash flow guidance, with management projecting mid-single-digit revenue declines for Q3, highlighting significant uncertainties regarding the company's profitability and market share moving forward.
See More
Coty Faces Securities Class Action Lawsuit Amid Operational Issues
- Lawsuit Background: Coty Inc. is facing a securities class action lawsuit following its Q2 2026 earnings report, which revealed serious operational issues, representing investors who purchased shares between November 5, 2025, and February 4, 2026, indicating strong investor dissatisfaction with the company's transparency.
- Stock Price Impact: Following the abrupt departure of CEO Nabi, Coty's stock price fell over 8% on February 5, 2026, reflecting market pessimism regarding the company's future prospects, particularly after its performance failed to meet expectations.
- Financial Performance: The Q2 2026 report revealed that Consumer Beauty's operating income plummeted over 70% year-over-year, while Prestige fragrance operating income also fell over 18%, highlighting significant challenges the company faces in a competitive market.
- Investigation Progress: Hagens Berman is investigating whether Coty intentionally misled investors regarding its business trends, and if proven, this could have substantial implications for the company's reputation and future financing capabilities.
See More
Coty Inc. Faces Class Action Lawsuit for Misleading Statements
- Lawsuit Reminder: The Schall Law Firm is reminding investors of a class action lawsuit against Coty Inc. for violations of securities laws, concerning securities transactions from November 5, 2025, to February 4, 2026, with a deadline to contact the firm by May 22, 2026, to participate.
- False Statements: The complaint alleges that Coty made false and misleading statements regarding its growth prospects for fiscal year 2026, as the company’s Consumer Beauty segment was underperforming, leading to significant investor losses.
- Market Reaction: As the market became aware of Coty's true performance, investor losses intensified, indicating a significant discrepancy between the company's growth promises and actual market performance, which negatively impacted its stock price and investor confidence.
- Legal Consequences: The case has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who choose not to act may become absent class members, potentially forfeiting their claims.
See More
Coty Class Action Lawsuit Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Coty Inc. (NYSE: COTY) common stock between November 5, 2025, and February 4, 2026, that they must apply to be lead plaintiff by May 22, 2026, to participate in the class action, as those who do not will not be represented by counsel.
- Fee Arrangement: Investors joining the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, allowing investors to seek compensation without financial burden.
- Lawsuit Background: The lawsuit alleges that Coty made false and misleading statements during the class period, concealing the true state of its slowing growth in the beauty market, which led to investor losses when the truth emerged, highlighting underperformance in the consumer beauty sector.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, demonstrating its extensive experience and success in handling such cases.
See More
Multiple Companies Face Class Action Lawsuits
- Atara Biotherapeutics Lawsuit: Atara Biotherapeutics faces a class action lawsuit for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, potentially leading to significant negative impacts on the company's financial condition.
- Coty Performance Decline: Coty Inc. is under scrutiny in a class action lawsuit covering November 5, 2025, to February 4, 2026, with claims that its Consumer Beauty segment underperformed, increased marketing investments compressed margins, and slowing growth in the Prestige fragrance market rendered the company's positive statements misleading.
- Super Micro Sales Violations: Super Micro Computer is implicated in a class action lawsuit for the period from February 2, 2024, to March 19, 2026, alleging that a significant portion of its server sales to Chinese companies violated U.S. export control laws, with material weaknesses in compliance controls leading to misleading positive statements about the company's operations.
- ImmunityBio Capability Overstatement: ImmunityBio faces a class action lawsuit for the period from January 19, 2026, to March 24, 2026, alleging that executive Soon-Shiong materially overstated Anktiva's capabilities, resulting in misleading positive statements about the company's business and operations, which could undermine investor confidence.
See More
